-
Mashup Score: 12
In women with a history of venous thromboembolism, weight-adjusted intermediate-dose low-molecular-weight heparin during the combined antepartum and post-partum periods was not associated with a lower risk of recurrence than fixed low-dose low-molecular-weight heparin. These results indicate that low-dose low-molecular-weight heparin for thromboprophylaxis during pregnancy is the appropriate dose…
Source: The LancetCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Bivalirudin Found to be Safer and More Effective Than Heparin for Treating Heart Attack Patients Undergoing Percutaneous Coronary Intervention - 1 year(s) ago
November 14, 2022 — Bivalirudin is a safer and more effective anticoagulant than heparin for treating patients with the most serious type of heart attacks who undergo urgent percutaneous coronary intervention (PCI), and can lower the risk of death or major bleeding by 31 percent. These are findings from a new study led by researchers from the Icahn School of Medicine at Mount Sinai. This is the…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0
Heparin allergy is frequently suspected or expressed as a diagnosis by patients and physicians. The incident in question is usually poorly documented or not documented at all, and the suspicion is rarely proven by accurate diagnostic testing. However, the problem might turn urgent if a patient reporting a vague history of heparin allergy needs acute anticoagulation for prophylaxis or treatment…
Categories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 0Delayed-Type Heparin Allergy: Intravenous Tolerance Despite Inflammatory Skin Reaction After Subcutaneous Injection - 1 year(s) ago
Heparin allergy most frequently manifests as delayed-type hypersensitivity (DTH) causing an itchy inflammatory skin reaction at the site of subcutaneous injection. An important differential diagnosis is circumscribed skin necrosis due to heparin-induced thrombocytopenia.
Categories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 0ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopenia - 1 year(s) ago
Karnes and colleagues report on the results of a genome-wide association study to find predictors of heparin-induced thrombocytopenia, comparing patients with a
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2JBJS: Low-Molecular-Weight Heparin Is Superior to Aspirin in the Prevention of Thromboembolic Disease: Or Is It?* - 2 year(s) ago
Parvizi, Javad; DeMik, David E.; Dunbar, Michael; Hozack, William J.; Mont, Michael A.; Lachiewicz, Paul F. The Journal of Bone and Joint Surgery, Year: 2022, Volume: Publish Ahead of Print, Issue: , DOI: 10.2106/JBJS.22.01024
Source: jbjs.orgCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 1Heparin pretreatment may safely open arteries before STEMI cath - 2 year(s) ago
The “early reperfusion” associated with IRA patency at angiography “could have long-term benefit due to smaller infarct size.”
Source: www.mdedge.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 2
In COVID-19 ICU survivors the authors identified treatment with low- molecular-weight heparin as a predictor of improved physical component of QoL at 6 months.
Source: PubMedCategories: Anesthesiology, Latest HeadlinesTweet
-
Mashup Score: 4Heparin or nonheparin anticoagulants for VITT - 2 year(s) ago
In this issue of Blood, Singh et al1 examined the interaction of heparin, danaparoid, fondaparinux, and argatroban with antibodies against platelet factor 4 (PF
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Cost-effectiveness analysis of alternative anticoagulation in suspected heparin-induced thrombocytopenia - 2 year(s) ago
Key Point. Fondaparinux costs less and confers more benefits than argatroban in patients with suspected heparin-induced thrombocytopenia.
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet
Important RCT in this week's @TheLancet. In pregnant women with a history of venous thrombosis, fixed low dose LMWH was as good as intermediate dose LMWH. https://t.co/UiVbhPd8G1 #pregnancy #thrombosis #heparin https://t.co/MHER7CjK2s